Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis

JAMA Psychiatry. 2022 Feb 1;79(2):178-179. doi: 10.1001/jamapsychiatry.2021.3710.

Abstract

This study examines the association between increased hippocampal glutamate and higher total positive symptom severity in converters to psychosis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Female
  • Glutamic Acid / metabolism*
  • Hippocampus / metabolism*
  • Humans
  • Male
  • Patient Acuity
  • Psychotic Disorders / diagnosis
  • Psychotic Disorders / metabolism*
  • Young Adult

Substances

  • Glutamic Acid